Join Orange Biomed at the ADA Conference 2025 (85th Scientific Sessions) from June 20-23 in Chicago, IL, to explore OBM rapid A1c, a breakthrough in diabetes testing. Visit us at our Innovation Hub table for live demos and expert insights.
Over 1,075,000 adults in Illinois have diabetes. Every year, 58,000 more are diagnosed. Many people don’t know they have diabetes until it’s too late. Orange Biomed is making A1C testing faster, easier, and more affordable. It is important for people to be able to detect diabetes early, and our goal is to help them manage it better.
Orange Biomed is excited to participate in the ADA Scientific Sessions Conference 2025. This event gives us a chance to share our innovations and connect with experts in diabetes care. It’s a key moment for improving the future of diabetes management.
The ADA Scientific Sessions Conference 2025
The ADA Scientific Sessions Conference 2025 is a major event for diabetes care. It brings together experts to share new research and ideas. This year’s focus is on technology, patient care, and accessibility. These areas are key to improving diabetes management worldwide. Scientists, healthcare providers, and industry leaders from around the world will attend. It’s a chance to collaborate and learn from the best.
Addressing the Diabetes Epidemic in Chicago’s Marginalized Communities
The Urgent Need for Action in Chicago
Chicago’s low-income and minority communities face a serious diabetes crisis. In particular, areas around UI Health have much higher diabetes rates, ranging from 20-37%, as the rates are notably increasing for African-American and Hispanic populations. These communities experience a much higher rate of diabetes, with limited access to quality healthcare. Obesity rates are high, and early diagnosis is often missed.The need for immediate action is urgent to prevent further complications.
Local Organizations Working to Solve Diabetes Gaps
Organizations like the Chicago Diabetes Project and the AIHS Diabetes Prevention Program are already making strides in improving diabetes care. These local groups work to provide education, resources, and support to underserved communities. Their efforts are vital in reducing the diabetes care gap and ensuring that those who need help the most get the care and attention they deserve.
ADA 2025's Role in Local Change
ADA 2025 is a critical event that provides a chance to address diabetes challenges head-on. It brings attention to solutions that can directly impact Chicago’s most vulnerable communities. This event is an opportunity to spotlight programs, innovations, and strategies that can improve diabetes care and make a difference in local communities.
Orange Biomed’s Commitment to Local Chicago Communities
Empowering Chicago with OBM rapid A1c
Orange Biomed is dedicated to improving diabetes care in underserved Chicago areas. We aim to make diabetes monitoring more accessible with our OBM rapid A1c device. This at-home test is designed for individuals to check their A1C levels quickly and accurately.
Early detection and regular monitoring help manage diabetes before complications arise. Our mission is to make this potentially life-saving tool affordable and easy to use for everyone.
Impact at ADA 2025
At ADA 2025, Orange Biomed will showcase how we are changing diabetes care. We’ll highlight how the OBM rapid A1c is improving access to at-home monitoring in marginalized communities. Chicago faces unique challenges with healthcare access, and we are dedicated to supporting ongoing initiatives for better care.
By making diabetes testing faster, easier, and more affordable, we aim to empower communities to take charge of their health. Improving early detection as well as our focus on better monitoring of A1C will help lead to better health outcomes.
Connect with our experts at ADA 2025
Breaking Barriers in A1c Testing: Orange Biomed’s Revolutionary Approach
The Challenge with Current A1c Testing
Many existing A1C tests are slow, expensive, and inaccurate for some people. Tests can take a long time, require a lab visit, and don’t always work well for all ethnicities or hemoglobin variants.
How does OBM rapid A1c Solve for These Problems?
Orange Biomed’s OBM rapid A1c device is a portable and fast solution. It provides lab-quality results in just 5 minutes. The device is designed to be affordable and reusable, making it a long-term option for patients. Most importantly, it works accurately for all ethnicities, including those with hemoglobin variants.
Why OBM rapid A1c is Important for ADA 2025?
This device aligns with global efforts for early diabetes detection and at-home testing. At the ADA 2025, we’ll give a first look at this innovative device before it’s available in late 2025 or early 2026. This breakthrough will make diabetes care more accessible and faster for people everywhere.
How Does OBM rapid A1c Align with Key Themes of the ADA Scientific Sessions 2025?
Theme 1: The Role of Technology in Diabetes Management
- Fast, accurate A1C testing is crucial for better diabetes management.
- OBM rapid A1c uses advanced microfluidic technology, providing lab-quality results in just 5 minutes.
- It offers quick and accurate readings, helping patients and healthcare providers make informed decisions.
Theme 2: Accessibility and Affordability in Diabetes Care
OBM rapid A1c makes A1C testing affordable and accessible, allowing patients to test at home.It reduces the need for expensive lab visits, bridging the gap between traditional hospital tests and at-home monitoring.
Theme 3: Personalized Healthcare & Early Detection
OBM rapid A1c enables accurate monitoring, which is vital for managing diabetes. This device allows patients to check their AIC levels regularly and adjust their diabetes treatment as needed. Early diagnosis and continuous monitoring help prevent complications and improve health outcomes.
What to Expect from Orange Biomed at the ADA Conference?
- Live Demos of OBM rapid A1c
Experience the next-generation diabetes testing device with live demonstrations. See how the OBM rapid A1c provides lab-quality results in just 5 minutes.
- Exclusive Speaker Sessions
Learn about the latest clinical research on A1C accuracy and advancements.
Discover how OBM rapid A1c is shaping the future of diabetes management.
- Meet the Experts
Engage with Orange Biomed’s scientists and product innovators.
Ask questions and gain insights into the future of diabetes testing.
Location and Timing:
- Presentation: Saturday, June 21, 2:40 pm – 3:00 pm
- Where to Find Orange Biomed: Innovation Hub, Exhibit Hall
- Poster Presentation (TBA)
Join Us at the ADA Conference 2025!
Be part of the future of diabetes care-experience OBM rapid A1c at the ADA Scientific Sessions Conference 2025.
